Pharma Deals Review, Vol 2002, No 28 (2002)

Font Size:  Small  Medium  Large

IDEC and Caprion Pharmaceuticals to Search for Novel Cancer Antigen Targets

Business Review Editor

Abstract


IDEC Pharmaceuticals enlisted Caprion to collaborate on the discovery of novel antigen targets in the development of anticancer therapeutics using Caprion’s proprietary subcellular proteomics discovery platform CellCarta™.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.